Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Hina Patel"'
Autor:
Jinming Yu, Andrés Cardona, Andrea Ardizzoni, Delvys Rodriguez-Abreu, Sergio Azevedo, Belen Rubio-Viqueira, Jorge Alatorre-Alexander, Hans J M Smit, Konstantinos Syrigos, Kerstin Trunzer, Hina Patel, Jonathan Tolson, Pablo D Perez-Moreno
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Atezolizumab treatment improves survival, with manageable safety, in patients with previously treated advanced/metastatic non-small cell lung cancer. The global phase III/IV study TAIL (NCT03285763) was conducted to evaluate the safety and
Externí odkaz:
https://doaj.org/article/ff460346035746668e4d5b72630465b6
Longitudinal impact of a pre‐populated default quantity on emergency department opioid prescriptions
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 2, Iss 1, Pp n/a-n/a (2021)
Abstract Objective Previously published studies indicate that a pre‐populated default quantity may decrease opioid amounts on discharge prescriptions from the emergency department (ED). However, the longitudinal effect of defaulted quantities has n
Externí odkaz:
https://doaj.org/article/33dbde7612cd4cf1aea047ef6bc58b9a
Autor:
Jihad Slim MD, Humberto Jimenez PharmD, Darren Culshaw PharmD, Hina Patel PharmD, Kenneth C. Lamp PharmD
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 14 (2015)
Objectives: This study was conducted to evaluate the clinical experience with daptomycin in the treatment of resistant gram-positive infections (GPIs) in patients with HIV infection. Methods: Using a retrospective, multicenter, and observational regi
Externí odkaz:
https://doaj.org/article/5fceada6486d4e998ef0ba07a06af2e3
Publikováno v:
Molecular Cancer Therapeutics. 20:2519-2526
Immune-related pneumonitis is an important toxicity associated with checkpoint inhibitor therapy with anti–PD-1 or anti–PD-L1 antibodies, often necessitating discontinuation of treatment. Development of methods to mitigate checkpoint inhibitor–
Autor:
Hina, Patel, Thanh G N, Ton, Jessica, Davies, Simon, Fear, Carolin, Block, Kunihiko, Tanaka, Danny, Gonzalez, Roger, Mutter, Noelia, Alfaro-Oliver, Ignacio, Mendez, Nawab, Qizilbash
Publikováno v:
Pharmaceutical Medicine
Background A Guide for Healthcare Professionals (HCP Guide) and patient alert card (PAC) for atezolizumab as additional risk minimization measures for physicians were distributed to raise awareness and help in the detection and management of immune-r
Autor:
Hina Patel, Supria Batra
Publikováno v:
Journal of Cardiac Failure. 29:692-693
Autor:
Hari Mohan Singh, Hina Patel
A Quasi-experimental study was conducted to assess the effectiveness of intradialytic exercise on haemodialytic patients in selected areas of Gandhinagar. The study was conducted among the haemodialytic patients group in selected areas of Gandhinagar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f1f36ebf6bb3d923997f49e6b82155
Publikováno v:
Journal of Cardiac Failure. 29:702
Autor:
Yu Deng, Mark A. Socinski, Hina Patel, Geetha Shankar, Denis Moro-Sibilot, Martin Früh, Shelley Coleman, Wei Yu, Elisabeth Piault, Martin Reck, Mikhail Shtivelband, T. Wehler, José Luis González Larriba, Carlo Barone, Anthony Lee, Naoyuki Nogami, Jeffrey Rothenstein, Francisco Orlandi, Claudia Kelsch
Publikováno v:
Journal of Clinical Oncology
PURPOSE Atezolizumab, bevacizumab, carboplatin, and paclitaxel (ABCP) demonstrated survival benefit versus bevacizumab, carboplatin, and paclitaxel (BCP) in chemotherapy-naïve nonsquamous non–small-cell lung cancer (NSCLC). We present safety and p
Introduction:Stem cells have tremendous promise to helping us to understand and treat a range of various diseases, injuries and other health related conditions. Their potential is evident in the use of cord blood stem cells to treat diseases of the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6aac6b53bcbdb6df52150068cce6ae0